silx
silx settles into maintenance a release after its PySide6 migration
A side-by-side editorial comparison of OpenCTI and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
OpenCTI spends a release unblocking queues and hardening upserts
7.260817.0 is a fix release. The most consequential item is malformed STIX messages nacking forever and blocking worker queues indefinitely — a stall in the ingestion path rather than a display bug. Alongside it: upsert clearing an existing createdBy when incoming confidence is higher, draft upserts crashing on existing attack patterns, OTP handling in the stream middleware, and case template relation authorization. Score fields were added to threat actor groups, intrusion sets and malware.
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
7.260817.0 is a fix release. The most consequential item is malformed STIX messages nacking forever and blocking worker queues indefinitely — a stall in the ingestion path rather than a display bug. Alongside it: upsert clearing an existing createdBy when incoming confidence is higher, draft upserts crashing on existing attack patterns, OTP handling in the stream middleware, and case template relation authorization. Score fields were added to threat actor groups, intrusion sets and malware.
The platform's feature energy went into the connector catalog and integrations rework in July, and the releases since have been consolidating: mass operations on relation times, shareable saved searches, and now a pass over ingestion robustness. Adding score to more entity types continues the slow enrichment of the data model that runs underneath the feature work.
Given score arriving on three entity types in one release, expect it to keep spreading across the data model, and the queue-blocking class of bug to draw more worker-side hardening.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either OpenCTI or pharmaverseadam.
silx settles into maintenance a release after its PySide6 migration
Plotly is turning its cloud into a metered compute platform with an enterprise on-ramp.
aniread stops asking you to know which tracker wrote the file
Rho's release machinery finally produced a stable build — and it shipped no new product.
Usermaven closed the loop: data comes in from anywhere, and now it goes back out.
Mimir's feed is a weekly Helm bot, with the 3.2 candidate the only real release in months
See all OpenCTI alternatives → · See all pharmaverseadam alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. OpenCTI is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. OpenCTI is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top OpenCTI alternatives in Analytics are ranked by recent ship velocity. Browse the "OpenCTI alternatives" section above for the current picks, or visit /alternatives/opencti for the full list with editorial commentary on each.
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.